We are live on ! Find out more
KA

Kearns & Associates Portfolio holdings

AUM $214M
1-Year Est. Return 23.8%
This Fund
S&P 500
This Quarter Est. Return
-2.86%
1 Year Est. Return
+23.8%
3 Year Est. Return
+69.41%
5 Year Est. Return
10 Year Est. Return
AUM
$186M
AUM Growth
-$7.7M
Cap. Flow
-$1.4M
Cap. Flow %
-0.75%
Top 10 Hldgs %
89%
Holding
41
New
1
Increased
7
Reduced
9
Closed
1

Sector Composition

Rank Sector Weight
1 Technology 3.82%
2 Financials 3.48%
3 Healthcare 1.88%
4 Communication Services 1.48%
5 Consumer Discretionary 0.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JPM icon
26
JPMorgan Chase
JPM
$937B
$579K 0.31%
1,967
JCI icon
27
Johnson Controls International
JCI
$88.9B
$488K 0.26%
3,725
-775
-17% -$100K
TMO icon
28
Thermo Fisher Scientific
TMO
$213B
$465K 0.25%
946
VNQ icon
29
Vanguard Real Estate ETF
VNQ
$39.3B
$462K 0.25%
5,212
+9
+0.2% +$825
WFC icon
30
Wells Fargo
WFC
$262B
$418K 0.22%
5,250
-1,750
-25% -$150K
COF icon
31
Capital One
COF
$132B
$396K 0.21%
2,170
IVV icon
32
iShares Core S&P 500 ETF
IVV
$882B
$395K 0.21%
604
MRSH
33
Marsh
MRSH
$91.4B
$372K 0.2%
2,145
-715
-25% -$129K
EQIX icon
34
Equinix
EQIX
$101B
$331K 0.18%
338
-47
-12% -$41.8K
GLD icon
35
SPDR Gold Trust
GLD
$131B
$295K 0.16%
685
MS icon
36
Morgan Stanley
MS
$331B
$247K 0.13%
1,500
QCOM icon
37
Qualcomm
QCOM
$156B
$245K 0.13%
1,905
SYK icon
38
Stryker
SYK
$128B
$237K 0.13%
720
-190
-21% -$68.2K
BKR icon
39
Baker Hughes
BKR
$60.2B
$229K 0.12%
+3,750
New +$217K
IWV icon
40
iShares Russell 3000 ETF
IWV
$19.9B
$204K 0.11%
549
HLF icon
41
Herbalife
HLF
$1.32B
-56,900
Closed -$733K

Similar funds

Kearns & Associates's Q1 2026 Portfolio in Review

As of Q1 2026, Kearns & Associates held 41 positions worth $186M, down 4% from $194M the previous quarter. Its ten largest holdings account for 89% of the portfolio.

Trading was light in Q1 2026: portfolio turnover was 4.9%. Kearns & Associates opened 1 new position and exited 1, leaving the 41-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 3.8% of assets, down from 4.2% a quarter earlier, followed by Financials and Healthcare.

  • Kearns & Associates's largest Q1 2026 buy was Baker Hughes: 3,750 shares worth $229K.
  • Kearns & Associates added most to Vanguard FTSE Developed Markets ETF in Q1 2026, an estimated $437K increase.
  • Kearns & Associates's biggest Q1 2026 reduction was Royalty Pharma, cutting an estimated $547K.
  • Kearns & Associates fully exited Herbalife in Q1 2026, selling an estimated $733K.
  • Kearns & Associates's ten largest holdings make up 89% of its $186M portfolio in Q1 2026.
  • Kearns & Associates opened 1 new position and closed 1 in Q1 2026.
  • Kearns & Associates's portfolio value fell 4% quarter-over-quarter to $186M.

Based on Kearns & Associates's 13F filing for Q1 2026, filed 20 Apr 2026.